Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register.
Pastore MC, Mandoli GE, Giannoni A, Benfari G, Dini FL, Pugliese NR, Taddei C, Correale M, Brunetti ND, Carluccio E, Mengoni A, Guaricci AI, Piscitelli L, Citro R, Ciccarelli M, Novo G, Corrado E, Pasquini A, Loria V, Degiovanni A, Patti G, Santoro C, Moderato L, Malagoli A, Emdin M, Cameli M; Collaborators: DISCOVER-ARNI Collaborators; Rosa G, Magnesa M, Mazzeo P, De Carli G, Bellino M, Iuliano G, Casciano O, Binno S, Canepa M, Tondi S, Cicoira M, Mega S. Pastore MC, et al. Among authors: canepa m. Eur Heart J Open. 2021 Dec 21;2(1):oeab046. doi: 10.1093/ehjopen/oeab046. eCollection 2022 Jan. Eur Heart J Open. 2021. PMID: 35919657 Free PMC article.
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction.
Masini M, Elia E, Vianello PF, Bertero G, Rossi P, Ameri P, Chiarella F, Brunelli C, Porto I, Sartori P, Canepa M. Masini M, et al. Among authors: canepa m. J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):118-125. doi: 10.2459/JCM.0000000000001085. J Cardiovasc Med (Hagerstown). 2021. PMID: 32941323
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey.
Tini G, Cappelli F, Biagini E, Musumeci B, Merlo M, Crotti L, Cameli M, Di Bella G, Cipriani A, Marzo F, Guerra F, Forleo C, Gagliardi C, Zampieri M, Carigi S, Vianello PF, Mandoli GE, Ciliberti G, Lichelli L, Mariani D, Porcari A, Russo D, Licordari R, Ponziani A, Porto I, Perfetto F, Autore C, Rapezzi C, Sinagra G, Canepa M. Tini G, et al. Among authors: canepa m. ESC Heart Fail. 2021 Aug;8(4):3369-3374. doi: 10.1002/ehf2.13411. Epub 2021 May 14. ESC Heart Fail. 2021. PMID: 33988312 Free PMC article.
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study.
Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Favale S, Di Bella G, Dore F, Lombardi CM, Pavasini R, Rella V, Palmiero G, Caiazza M, Albanese M, Guaricci AI, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Sfriso E, Di Ienno L, De Carli G, Giacomin E, Spini V, Milidoni A, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G. Merlo M, et al. Among authors: canepa m. Eur J Prev Cardiol. 2022 May 5;29(5):e173-e177. doi: 10.1093/eurjpc/zwab127. Eur J Prev Cardiol. 2022. PMID: 34499711 Free article. No abstract available.
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis.
Ameri P, De Marzo V, Zoccai GB, Tricarico L, Correale M, Brunetti ND, Canepa M, De Ferrari GM, Castagno D, Porto I. Ameri P, et al. Among authors: canepa m. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):768-776. doi: 10.1093/ehjcvp/pvab088. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34928347 Free article.
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey.
Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Perfetto F, Favale S, Di Bella G, Dore F, Girardi F, Tomasoni D, Pavasini R, Rella V, Palmiero G, Caiazza M, Carella MC, Igoren Guaricci A, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Rossi M, Varrà GG, Saro R, Di Ienno L, De Carli G, Giacomin E, Arzilli C, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G. Merlo M, et al. Among authors: canepa m. Eur J Heart Fail. 2022 Aug;24(8):1377-1386. doi: 10.1002/ejhf.2504. Epub 2022 May 10. Eur J Heart Fail. 2022. PMID: 35417089 Free article. Clinical Trial.
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study.
Tini G, Milani P, Zampieri M, Caponetti AG, Fabris F, Foli A, Argirò A, Mazzoni C, Gagliardi C, Longhi S, Saturi G, Vergaro G, Aimo A, Russo D, Varrà GG, Serenelli M, Fabbri G, De Michieli L, Palmiero G, Ciliberti G, Carigi S, Sessarego E, Mandoli GE, Ricci Lucchi G, Rella V, Monti E, Gardini E, Bartolotti M, Crotti L, Merli E, Mussinelli R, Vianello PF, Cameli M, Marzo F, Guerra F, Limongelli G, Cipriani A, Perlini S, Obici L, Perfetto F, Autore C, Porto I, Rapezzi C, Sinagra G, Merlo M, Musumeci B, Emdin M, Biagini E, Cappelli F, Palladini G, Canepa M. Tini G, et al. Among authors: canepa m. Eur J Heart Fail. 2023 Jun;25(6):845-853. doi: 10.1002/ejhf.2823. Epub 2023 Mar 15. Eur J Heart Fail. 2023. PMID: 36907828
332 results